Brief: Oramed And HTIT To Create A Joint Venture To Advance Oral Drug Delivery Technology Globally
02/08/2023 13:41
Aug 2 (Reuters) - Oramed Pharmaceuticals Inc ORMP.O :
* ORAMED SIGNS TERM SHEET WITH HTIT TO CREATE A JOINT
VENTURE TO
ADVANCE ORAL DRUG DELIVERY TECHNOLOGY GLOBALLY
* ORAMED PHARMACEUTICALS INC - AS PART OF JOINT VENTURE,
HTIT WILL
MAKE AN INITIAL INVESTMENT OF $60 MILLION, WHILE ORAMED WILL
INVEST $10 MILLION
* ORAMED PHARMACEUTICALS INC - ORAMED AND HTIT WOULD
INITIALLY
HOLD EQUAL SHARES IN JV, WITH EACH OWNING 50% OF EQUITY
Source text for Eikon: ID:nPn9mlmnXa
Further company coverage: ORMP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oramed Pharmaceuticals
See all newsBrief: Nano Dimension Appoints Nadav Kidron To Board Of Directors To Chair Strategy And Capital Allocation Committee
Oramed Pharmaceuticals Inc expected to post earnings of 43 cents a share - Earnings Preview
Brief: Oramed And Lifeward Announce Strategic Transaction
Brief: Oramed Receives $18 Million Payment From Scilex Holdings
Brief: Oramed Reports Fiscal Third Quarter 2025 Financial Results